Delbert G. Robinson, MD

Northwell, New Hyde Park, New York (Kane, Robinson); Feinstein Institutes for Medical Research, Northwell Health, Manhasset New York; Department of Psychiatry, Zucker School of Medicine at Hofstra/Northwell, Hempstead, New York

  • 9Articles
  • 63.9KReads1
  • 2004–2026Active
  • 59Collaborators
  • 403Citations2

1 Read counts for articles published before 2020 may include some non-human traffic.

2 Citation counts provided by Crossref.

About

Delbert G. Robinson, MD, has published extensively on schizophrenia and schizoaffective disorders, major depressive disorder, and patient care. His work includes topics such as optimizing antipsychotic treatment through blood level monitoring, early-phase schizophrenia treatment with long-acting injectable medications, and management of antipsychotic side effects in elderly patients. Robinson has contributed to studies on treatment algorithms and early intervention strategies for first-episode psychosis. His research has appeared in Psychiatrist.com publications from 2004 to 2020.

Publications

JCP
Long-Acting Injectable Antipsychotics and Clozapine in Coordinated Specialty Care: Data From EPINET
Original Research

Long-Acting Injectable Antipsychotics and Clozapine in Coordinated Specialty Care: Data From EPINET

September 14, 2026

Data from the EPINET project reveal wide variation in the prescription of LAIs and clozapine across first-episode specialty care clinics.
, , , et al
JCP
Consensus Statement

Consensus on Monitoring Blood Antipsychotic Levels

May 19, 2020

The quantification of antipsychotic levels in blood, or therapeutic drug monitoring (TDM), could aid clinicians in numerous challenging scenarios. Learn more about using TDM for dosing decisions in this...
, , , et al
JCP
Original Research

Early Phase Schizophrenia and LAI

April 23, 2019

Read a study examining if patients in the early phase of schizophrenia would accept LAI antipsychotic treatment.
, , , et al
JCP
Original Research

The RAISE: First-Episode Psychosis

March 25, 2015

Read an article describing The RAISE Early Treatment Program for First-Episode Psychosis, the background and study design of the program.
, , , et al
JCP
Article

Time to Treatment Response in First-Episode Schizophrenia: Should Acute Treatment Trials Last Several Months?

September 6, 2011

, , , et al
JCP
Original Research

The Texas Medication Algorithm Project Antipsychotic Algorithm for Schizophrenia: 2006 Update

November 15, 2007

, , , et al
JCP
Academic Highlights

New Developments in the Treatment of Schizophrenia.

March 15, 2007

, , , et al
JCP
Original Research

High-Dose Sertraline Strategy for Nonresponders to Acute Treatment for Obsessive-Compulsive Disorder: A Multicenter Double-Blind Trial

January 16, 2006

, , , et al
PCC
Article

Recognizing and Managing Antipsychotic Drug Treatment Side Effects in the Elderly

May 1, 2004

, ,

Physicians Postgraduate Press, Inc. (PPP) makes no warranties about the accuracy or completeness of any information published in The Journal of Clinical Psychiatry or other PPP materials, and disclaims liability for any use or non-use of that information. Clinicians should not rely solely on these materials and should exercise their own professional judgment when making patient care decisions on an individualized basis.

Learn More About Ketamine and Psychedelics

Listen to the Podcast
The Journal of Clinical Psychiatry podcast cover with Benjamin Brody, MD

Subscribe to read
more articles

Subscribe